Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report.

Powell, Nicholas R; Shugg, Tyler; Ly, Reynold C; Albany, Costantine; Radovich, Milan; Schneider, Bryan P; Skaar, Todd C

Powell, Nicholas R; Shugg, Tyler; Ly, Reynold C; Albany, Costantine; Radovich, Milan; Schneider, Bryan P; Skaar, Todd C.

Afiliação

Powell NR; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, United States.
Shugg T; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, United States.
Ly RC; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, United States.
Albany C; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Radovich M; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Schneider BP; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Skaar TC; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, United States.

Front Oncol ; 11: 809527, 2021.

Article em En | MEDLINE | ID: mdl-35174070

Palavras-chave

CYP3A4; DOCETAXEL; case report; pharmacogenetics; pneumonitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google